What Does Merck Do?

Total employees43096
HeadquartersKenilworth
FoundedN/A

Merck & Co., Inc., known as MSD outside the United States and Canada, is a premier, research-intensive biopharmaceutical company. For more than 130 years, Merck has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases.

Where Is Merck's Headquarters?

HQ Function

Serves as the global strategic command center, housing corporate administration, primary research and development leadership, and operational oversight for worldwide activities.

Notable Features:

Modern campus with state-of-the-art research laboratories, advanced collaborative workspaces, environmentally conscious design elements, and employee wellness facilities.

Work Culture:

The headquarters fosters a culture centered on scientific innovation, a patient-first mindset, unwavering ethical conduct, diversity and inclusion, and a highly collaborative environment geared towards achieving breakthroughs in medicine.

HQ Significance:

The Kenilworth headquarters is the central nervous system for Merck's global operations, driving its extensive research pipeline and corporate strategy to address unmet medical needs worldwide and bring hope to patients.

Values Reflected in HQ: The headquarters' design and operations reflect Merck's core values, including a profound commitment to scientific excellence, relentless innovation, sustainability in practice, and fostering a collaborative, inclusive environment for its employees to thrive.

Location:

Merck & Co., Inc. (MSD outside the U.S. and Canada) maintains a significant global presence, operating in over 140 countries. Its worldwide functions include extensive research and development laboratories, state-of-the-art manufacturing facilities, and robust sales, marketing, and distribution networks. The company supports a broad portfolio in key therapeutic areas such as oncology, vaccines, infectious diseases, cardiometabolic disorders, and animal health, ensuring its innovative products reach patients and customers globally.

Street Address:

2000 Galloping Hill Road

City:

Kenilworth

State/Province:

New Jersey

Country:

USA

Where Else Does Merck Operate Around the World?

Boston, Massachusetts, USA

Address: 33 Avenue Louis Pasteur, Boston, MA 02115, USA

Drives early-stage scientific innovation and pipeline development for Merck's global portfolio, fostering collaborations with leading academic institutions and biotech companies in the New England innovation corridor.

Singapore, Singapore

Address: 150 Beach Road, #32-01 Gateway West, Singapore 189720

Coordinates and supports Merck's (MSD's) business activities throughout the Asia Pacific region, ensuring patient access to the company's innovative medicines and vaccines and adapting global strategies to local market needs.

Rahway, New Jersey, USA

Address: 126 E Lincoln Ave, Rahway, NJ 07065, USA

Contributes significantly to Merck's drug discovery, development, and manufacturing capabilities, particularly for the North American market and global supply chain.

Buying Intent Signals for Merck

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Merck? Meet the Executive Team

As of April 2025, Merck' leadership includes:

Robert M. Davis - Chairman and Chief Executive Officer
Caroline Litchfield - Executive Vice President and Chief Financial Officer
Dr. Dean Y. Li - Executive Vice President and President, Merck Research Laboratories
Jannie Oosthuizen - Executive Vice President and President, Merck Human Health
Crystal E. Ashby - Executive Vice President and Chief People Officer

Who's Investing in Merck?

Merck has been backed by several prominent investors over the years, including:

The Vanguard Group, Inc.
BlackRock Inc.
State Street Corporation
Capital World Investors
Wellington Management Company, LLP

What Leadership Changes Has Merck Seen Recently?

Hire2
Exits1

Merck & Co., Inc. has experienced several key leadership appointments and transitions over the past year (May 2023 - May 2024), notably within its Research Laboratories and Animal Health divisions, underscoring strategic shifts and continued focus in these areas.

Departures

Richard R. DeLuca Jr., Richard R. DeLuca Jr. retired as President of Merck Animal Health, effective June 1, 2023.

New Appointments:

George Addona, George Addona appointed to lead key research and development functions within MRL, effective May 1, 2023.
Joseph Funk, Joseph Funk appointed President of Merck Animal Health, effective June 1, 2023, to succeed Richard R. DeLuca Jr.

What Technology (Tech Stack) Is Used byMerck?

Discover the tools Merck uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Merck Email Formats and Examples

Merck & Co., Inc. primarily utilizes a standard corporate email format, typically combining employee names with the company domain. The most common pattern is [first name].[last name]@merck.com. Variations such as [first initial][last name]@merck.com might also be in use.

firstname.lastname@merck.com or firstinitiallastname@merck.com

Format

jane.doe@merck.com

Example

90%

Success rate

What's the Latest News About Merck?

Merck NewsroomMay 30, 2024

Merck's KEYTRUDA® Plus Chemoradiotherapy Shows Significant Overall Survival Improvement in High-Risk Locally Advanced Cervical Cancer

Merck announced positive results from the Phase 3 KEYNOTE-A18 trial, where KEYTRUDA (pembrolizumab) combined with chemoradiotherapy (CRT) demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) compared to CRT alone for patients with newly diagnosed high-risk locally advanced cervical cancer....more

Merck NewsroomMay 28, 2024

Merck Reports Positive Phase 3 Trial Results for Investigational Chronic Cough Treatment

Merck shared positive topline results from its COUGH-301 and COUGH-302 Phase 3 trials evaluating an investigational fixed-dose combination of gefapixant and budesonide in adults with refractory or unexplained chronic cough. The studies met their primary efficacy endpoints....more

Merck NewsroomMay 16, 2024

Merck Announces Phase 3 STELLAR Trial for Subcutaneous KEYTRUDA Met Primary Endpoints in Resectable NSCLC

Merck announced that the Phase 3 STELLAR trial evaluating a subcutaneous formulation of KEYTRUDA (pembrolizumab) met its primary endpoints of pharmacokinetics (noninferior trough concentration [Ctrough] at Cycle 4) and pathologic complete response (pCR) in patients with resectable non-small cell lung cancer (NSCLC)....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Merck, are just a search away.